The Role of Microbiota on the Development of Lung Cancer

May 31, 2019 updated by: Xiaorong Dong
Relationship between human microbiota and epidemiology of lung cancer

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

In this study,We aim to find some kinds of human microbiota , which were associated with development of non-small cell lung cancer.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Hubei
      • Wuhan, Hubei, China, 430000
        • Recruiting
        • Union Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Just confirmed non-small cell lung cancer patients

Description

Inclusion Criteria:

  • non-small cell lung cancer patients

Exclusion Criteria:

  • long-term workers in the polluted environment, Patients who had used antibiotics within 1 month before sampling,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
NCSLC group
NSCLC patients,including stage I to stage IV.
Other: without intervention type
Without intervention,this study is just an observational study.
Healthy subjects
healthy subjects
Other: without intervention type
Without intervention,this study is just an observational study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship Between Human Microbiota and Epidemiology of Lung Cancer
Time Frame: 1 year
Find some human microbes that are associated with the development of lung cancer, we can detect these human microbiological content as a biomarker of lung cancer.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Xiaorong Dong

Investigators

  • Study Director: dong xiaorong, Dr, china government

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 30, 2018

Primary Completion (ANTICIPATED)

January 30, 2020

Study Completion (ANTICIPATED)

March 30, 2020

Study Registration Dates

First Submitted

January 21, 2018

First Submitted That Met QC Criteria

March 5, 2018

First Posted (ACTUAL)

March 6, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 4, 2019

Last Update Submitted That Met QC Criteria

May 31, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 745435

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on without intervention type

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe